| 25-hydroxy vitamin D | 245 |
| Acute appendicitis | 143 |
| Acute pancreatitis | 157 |
| Adult tuberculosis | 115 |
| Aflibercept | 170 |
| Airway obstruction | 88 |
| Albumin | 60 |
| Alopecia | 33 |
| Anaphylactic reaction | 257 |
| Androgenetic alopecia | 33 |
| Anesthesia | 102, 186 |
| Anti-vascular endothelial growth factor | 170 |
| Antral follicle | 211 |
| Autoimmune disease | 15 |
| Bcl-2 | 193 |
| Benign paroxysmal positional vertigo | 245 |
| Benign prostatic hyperplasia | 23 |
| Bethesda System | 71 |
| Bilateral retinal vein occlusion | 111 |
| Biochemical recurrence | 241 |
| Bladder cancer | 19, 92, 162 |
| Blood count | 143 |
| Brain damage | 83 |
| Branch retinal vein occlusion | 11 |
| Calcinosis | 132 |
| Cardiac involvement | 167 |
| Cardiopulmonary resuscitation | 113 |
| Carpal tunnel syndrome | 220 |
| CD30 positivity | 249 |
| Cesarean delivery | 1 |
| Cesarean section | 54 |
| Chemotherapy | 162 |
| Chronic Obstructive Pulmonary disease | 147 |
| Cleidocranial dysplasia | 253 |
| COPD exacerbation | 88 |
| Cord blood | 49 |
| CRVO | 111 |
| Culture | 211 |
| Curative radiotherapy | 241 |
| Cutaneous lymphoma | 249 |
| Dermoid cyst | 77 |
| Dexmedetomidine | 205 |
| Diabetic macular edema | 170 |
| Diagnosis | 6 |
| Differential diagnosis | 175 |
| Dupuytren’s contracture | 43 |
| Dupuytren’s disease | 43 |
| Echocardiography | 167 |
| Ectopic pregnancy | 201 |
| Emergency department | 6 |
| End stage renal failure | 83 |
| Endovascular treatment | 229 |
| Enlarged fontanels | 253 |
| Epidermal growth factor | 193 |
| Epilepsy | 175 |
| Episiotomy | 38 |
| Erectile dysfunction | 23 |
| Etiology | 111, 132 |
| Extrapulmonary tuberculosis | 115 |
| Eysenck’s Personality inventory | 153 |
| Fasciectomy | 43 |
| Fetal thyroid dose | 120 |
| Fetus dose | 120 |
| FEV1 | 88 |
| Fibulin 5 | 182 |
| Fine needle aspiration biopsy | 71 |
| Fluorine 18-fluorodeoxyglucose | 27 |
| Folic acid | 66 |
| Follicle-stimulating hormone | 211 |
| Gallium-68 prostate-specific membrane antigen positron emission tomography-computed | 241 |
| Tomography | 241 |
| General anesthesia | 220 |
| Gold dust | 257 |
| Gonadotropin-releasing hormone agonist | 211 |
| Gonadotropin-releasing hormone antagonist | 211 |
| Guidelines | 102, 186 |
| Head and neck | 77 |
| Hematocrit decrease | 1 |
| Hemodialysis | 83 |
| Hemoglobin decrease | 1 |
| Hepatosteatosis | 27 |
| Homocysteine | 197 |
| Hybrid treatment | 229 |
| Hysteroscopy | 126 |
| IIEF | 23 |
| Infertility | 126 |
| Inspiratory capacity | 147 |
| Insulin-like growth factor 1 | 182 |
| Integrated pulmonary index | 113 |
| International Prostate Symptom score | 23 |
| Intracranial involvement | 77 |
| Intraretinal cyst diameter | 11 |
| Intravaginal ejaculation latency time | 66 |
| Kounis syndrome | 257 |
| Laryngeal mask airway | 205 |
| Lidocaine | 205 |
| Lower urinary tract symptoms | 23 |
| Lymphocyte | 157 |
| Macula | 15 |
| Macular edema | 11 |
| Malnutrition | 60 |
| Maras powder | 233 |
| Maternal outcomes | 54 |
| Matrigel | 211 |
| Mean platelet volume | 143 |
| Methotrexate | 201 |
| Mitral valve | 167 |
| Mucopolysaccharidosis | 167 |
| Negative expiratory pressure | 147 |
| Neonatal outcomes | 54 |
| Neuron-specific enolase | 83 |
| Neurotrauma | 102, 186 |
| Neutrophil | 157 |
| Neutrophil lymphocyte ratio | 157 |
| Neutrophil/leukocyte ratio | 143 |
| Newborn | 49 |
| Nutrition | 60 |
| Off-label prescription | 19 |
| Optical coherence tomography | 11, 15 |
| Osteosarcoma | 193 |
| Oxidative stress | 49 |
| Pain | 220 |
| Palmar contracture | 43 |
| Peripheral arterial disease | 229 |
| Peripheral vertigo | 245 |
| Peritoneal dialysis | 83 |
| Placental growth factor | 98, 137 |
| Platelet | 33 |
| Platelet count | 143 |
| Platelet-rich plasma | 33 |
| Positron emission tomography | 27 |
| Postpartum hemorrhage | 38 |
| Preeclampsia | 98, 137 |
| Pregnancy outcomes | 126 |
| Pregnancy-associated plasma protein A | 137 |
| Premature ejaculation | 66 |
| Preschool children | 175 |
| Primary cutaneous anaplastic large cell lymphoma | 249 |
| Prognosis | 197 |
| Prophylaxis | 224 |
| Psychotism | 153 |
| Pulmonary thromboembolism | 6 |
| Radiation dose | 120 |
| Radical prostatectomy | 241 |
| Ranibizumab | 170 |
| Recurrence | 92 |
| Relative macrocephaly | 253 |
| Renal cell cancer | 19 |
| Return of spontaneous circulation | 113 |
| Rheumatoid arthritis | 15 |
| Risk | 224 |
| Rs6214 | 182 |
| S-100B | 83 |
| Scrotum | 132 |
| Second phase of the labor | 54 |
| SEndoglin | 137 |
| Serology | 197 |
| SFlt | 98 |
| Single dose | 201 |
| Small cell cancer | 162 |
| Smoking | 49, 92 |
| Sputum culture | 88 |
| Squamous cell cancer | 162 |
| Standardized uptake value | 27 |
| Sudden sensorineural hearing loss | 197 |
| Systemic lupus erythematosus | 15 |
| Testicular cancer | 19 |
| Thoracic trauma | 102, 186 |
| Thyroid cancer | 71 |
| Thyroid nodule | 71 |
| Thyroidectomy | 71 |
| Timing of episiotomy repair | 38 |
| Tobacco | 233 |
| Tobacco smokeless | 233 |
| Tuberculosis | 115 |
| Umbilical hernia | 215 |
| Urinary incontinence | 182 |
| Uterine artery | 137 |
| Venous thromboembolism | 224 |
| Ventral hernia | 215 |
| Ventralex™ hernia patch | 215 |
| Vitamin B12 | 66 |
| Vocal cord nodules | 153 |
| Wide awake local anesthesia no tourniquet | 220 |